Imcyse Obtains Authorization To Launch Phase 1b Trial In Type 1 Diabetes - Clinical Leader

Imcyse Obtains Authorization To Launch Phase 1b Trial In Type 1 Diabetes Clinical Leader “Imcyse has developed a uniquely innovative technology that appears particularly suitable for type 1 diabetes,” said professor Christian Boitard, head of the Inserm Unit U1016 and head of diabetes medicine at Cochin Hospital (Paris, France) and the ...